STXS vs TDG · rev $14.0M vs P/E 41, rev $8.83B
Stereotaxis Inc (STXS) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Stereotaxis Inc (STXS) is a medical instruments & supplies company listed on AMEX.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported STXS revenue for 2026-06-30 was $14.0M. Net income was -$10.3M. STXS currently screens at market cap $174.0M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
STXS currently screens at market cap $174.0M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the STXS and TDG stock pages for the full models.
Not investment advice.